Medicus Pharma (MDPLD) | Stock Overview & Key Data
Medicus Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $3.00 on January 24, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medicus Pharma
MDPLD
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | N/A | N/A | N/A | N/A | N/A | N/A |
|
Eli Lilly and
LLY
|
821.31B Mega-cap | -1.72% | 12.38% | 14.18% | 6.32% | 4.53% | 38.28% | 153.07% | 418.42% | 1,433.98% | 2,935.09% | 1,988.48% |
| 555.84B Mega-cap | 1.51% | 3.95% | -3.10% | 10.03% | 13.65% | 53.32% | 46.67% | 48.70% | 108.58% | 263.36% | 290.52% | |
|
AbbVie
ABBV
|
351.47B Mega-cap | 2.58% | 8.40% | 22.13% | 18.90% | 10.98% | 19.18% | 64.26% | 101.32% | 279.49% | 590.09% | 590.09% |
|
Merck & Co
MRK
|
283.10B Mega-cap | -3.87% | 3.16% | -0.46% | 14.60% | 7.94% | 45.70% | 8.90% | 55.40% | 123.23% | 252.74% | 262.85% |
|
Amgen
AMGN
|
187.93B Large-cap | 1.39% | 7.42% | -4.29% | 7.75% | 6.99% | 20.32% | 54.66% | 48.82% | 137.40% | 512.31% | 431.58% |
Ownership & Short Interest
Calculate Your Medicus Pharma Investment Returns
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MDPLD's 52-week high and low?
- In the last 52 weeks, Medicus Pharma reached a high of $6.00 (on September 16, 2024) and a low of $1.80 (on November 21, 2024).
- What is the market cap and P/E ratio for MDPLD?
- Curious about Medicus Pharma's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.47, and the forward P/E (looking ahead) is N/A.
- Does MDPLD pay dividends? If so, what's the yield?
- As for dividends, Medicus Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medicus Pharma's main competitors or similar companies to consider before investing?
When looking at Medicus Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eli Lilly and
LLY821.31B Healthcare Drug Manufacturers - General 38.28% 153.07% Johnson & Johnson
JNJ555.84B Healthcare Drug Manufacturers - General 53.32% 46.67% AbbVie
ABBV351.47B Healthcare Drug Manufacturers - General 19.18% 64.26% Merck & Co
MRK283.10B Healthcare Drug Manufacturers - General 45.70% 8.90% Amgen
AMGN187.93B Healthcare Drug Manufacturers - General 20.32% 54.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medicus Pharma Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Medicus Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -841.91%, the Debt to Equity ratio from the most recent quarter is 0.10, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MDPLD?
- Looking at Medicus Pharma's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of MDPLD stock is held by insiders and institutions?
- Wondering who owns Medicus Pharma stock? Company insiders (like executives and directors) hold about 55.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.